| Market Cap | $405.22M |
| 52-Wk High | $7.55 |
| 52-Wk Low | $7.55 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Calliditas Therapeutics AB - Ordinary Shares - Class B market cap is $405.22M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Calliditas Therapeutics AB - Ordinary Shares - Class B 52 week high is $7.55 as of October 04, 2023.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Calliditas Therapeutics AB - Ordinary Shares - Class B 52 week low is $7.55 as of October 04, 2023.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Calliditas Therapeutics AB - Ordinary Shares - Class B’s P/E ratio is -10.42.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Calliditas Therapeutics AB - Ordinary Shares - Class B P/B ratio is 7.1292.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Calliditas Therapeutics AB - Ordinary Shares - Class B 50-day moving average is $7.55.
Calliditas Therapeutics AB - Ordinary Shares - Class B has 178 employees.
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.